Ketorolac Tromethamine
NDC 17478-209
Product Information
Ketorolac Tromethamine is a ANDA-approved product labeled by Akorn. Ketorolac is used for the short-term treatment of moderate to severe pain. It is supplied as a product. This product entry covers the primary NDC 17478-209 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 17478-209?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- KETOROLAC TROMETHAMINE (UNII: 4EVE5946BQ)
- KETOROLAC (UNII: YZI5105V0L) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- OCTOXYNOL-40 (UNII: 9T1C662FKS)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 860107 - ketorolac tromethamine 0.5 % Ophthalmic Solution
- RxCUI: 860107 - ketorolac tromethamine 5 MG/ML Ophthalmic Solution
* Please review the full disclaimer at the bottom of this page.
Patient Education
Ketorolac Ophthalmic
Ophthalmic ketorolac is used to treat itchy eyes caused by allergies. It also is used to treat swelling and redness (inflammation) that can occur after cataract surgery. Ketorolac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the release of substances that cause allergy symptoms and inflammation.
[Learn More]
* Please review the full disclaimer at the bottom of this page.